Fission Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Fission Pharmaceuticals Private Limited

Fission Pharmaceuticals Private Limited, a struck off private limited company, was established on 25 September 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24304MH2019PTC330966. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.25 M.

Its leadership includes Kshitij Sushil Daruka (Director), Prakash Jeevanram Sanghai (Director), Sandeep Bansal (Director). It is based at 310, 3Rd Floor, Corporate Centre Nirmal Lifestyle, L.B.S Marg, Mulund(W), Mumbai, Maharashtra, 400080.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304MH2019PTC330966

  • Registration Number

    330966

  • Incorporation Date

    25 September 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.25 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.25 M
  • Company Age 6 Year, 6 Months
Company report

Fission Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fission Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Fission Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kshitij Sushil Daruka Director 25 Sep 2019 Current
Prakash Jeevanram Sanghai Director 25 Sep 2019 Current
Sandeep Bansal Director 25 Sep 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fission Pharmaceuticals.

Enhance accessibility to Fission Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fission Pharmaceuticals revenue growth over time
Fission Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fission Pharmaceuticals?

Unlock access to Fission Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fission Pharmaceuticals?

Unlock and access historical data on people associated with Fission Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fission Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fission Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fission Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Kshitij Sushil Daruka was appointed as a Director was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Prakash Jeevanram Sanghai was appointed as a Director was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 6 months . was documented.

  • Director Appointment

    Progress on Sandeep Bansal was appointed as a Director was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 6 months . was documented.

  • Company Incorporation

    The activity Fission Pharmaceuticals Private Limited was registered on 25 Sep 2019 with Roc Mumbai & aged 6 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fission Pharmaceuticals Private Limited?

The CIN of Fission Pharmaceuticals Private Limited is U24304MH2019PTC330966.

Where is Fission Pharmaceuticals Private Limited headquartered?

Fission Pharmaceuticals Private Limited is headquartered at 310, 3Rd Floor, Corporate Centre Nirmal Lifestyle, L.B.S Marg, Mulund(W), Mumbai, Maharashtra, 400080.

When was Fission Pharmaceuticals Private Limited incorporated?

Fission Pharmaceuticals Private Limited was incorporated on 25 September 2019.

Who are the current directors of Fission Pharmaceuticals Private Limited?

The current directors of Fission Pharmaceuticals Private Limited are

What is the primary industry of Fission Pharmaceuticals Private Limited?

The primary industry of Fission Pharmaceuticals Private Limited is Pharma.

Is Fission Pharmaceuticals Private Limited a listed company?

Fission Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Fission Pharmaceuticals Private Limited?

The authorized capital of Fission Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.25 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available